Market revenue in 2023 | USD 423.2 million |
Market revenue in 2030 | USD 658.4 million |
Growth rate | 6.5% (CAGR from 2023 to 2030) |
Largest segment | Outsourcing |
Fastest growing segment | Outsourcing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | In-house, Outsourcing |
Key market players worldwide | Genpact Ltd, Criterium Inc., Icon PLC, Wuxi AppTec Co Ltd, Medpace Holdings Inc, Charles River Laboratories International Inc, Labcorp Holdings Inc, FREYR Battery Inc, Pharmexon, Cambridge Design Partnership, Voisin Consulting Life Sciences, Accell, PAREXEL, Promedica International, PharmaLex, NDA Regulatory Service GmbH, QVigilance, BlueReg Group |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to regulatory affairs market will help companies and investors design strategic landscapes.
Outsourcing was the largest segment with a revenue share of 58.13% in 2023. Horizon Databook has segmented the Canada regulatory affairs market based on in-house, outsourcing covering the revenue growth of each sub-segment from 2018 to 2030.
Canada’s regulatory environment is governed by Health Canada and there has been tremendous support by the government in encouraging investment for clinical development and manufacture of biopharmaceutical products.
Budget 2016 highlights a significant investment in Health Infoway and the Center for Drug Research and Development in the next two years, which is expected to attract many biopharmaceutical companies.
A higher number of market entrants may result in an increased demand for regulatory services. Canada accounts for 4.0% of the total number of clinical trials and is fourth in number in terms of clinical sites. Presence of a well-established healthcare system and support by the government are expected to result in increased number of clinical trials in the region.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada regulatory affairs market , including forecasts for subscribers. This country databook contains high-level insights into Canada regulatory affairs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account